HMD 0.00% 2.3¢ heramed limited

The Phantom returns?? 500 licenses, must be our biggest yet.....

  1. 8,309 Posts.
    lightbulb Created with Sketch. 216
    The Phantom returns??

    500 licenses, must be our biggest yet..

    Just an opinion,

    TCG...


    Strategic collaboration signed with leading obstetricians and physician; appointed as key opinion leaders ● Binding two-year agreement signed with PHI Research, led by Associate Professor Paul Porter, joined by Dr Kym Jones; the leading clinical team and private obstetrician that led each of HeraCARE’s clinical trials as well as the rollout of HeraCARE within the public hospital at JHC;

    ● Paul and Kym to make up a newly formed medical advisory team, supporting HeraMED as HeraCARE experts and Key Opinion Leaders;

    ● Agreement also brings the two most experienced HeraCARE administrators responsible for supporting HeraCARE at JHC since 2020; Brooke Schneider and Emma Chambers, who will take on the roles of ‘HeraMED Navigators’. This is an important step, in the Australian commercialisation strategy of HeraCARE to provide local training and capability support to enhance the implementation process as HeraCARE is rolled out across new sites;

    ● Through this relationship, HeraMED will be able to collaborate with PHI Research to explore and identify medical and research grants and other non-dilutive funding sources in Australia; and

    ● In addition to the medical and clinical collaboration, education, and training for HeraMED, Paul and Kym will subscribe for up to 500 HeraCARE SaaS licenses for use in their private practices.
 
watchlist Created with Sketch. Add HMD (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
0.000(0.00%)
Mkt cap ! $14.56M
Open High Low Value Volume
2.3¢ 2.4¢ 2.3¢ $5.934K 249.2K

Buyers (Bids)

No. Vol. Price($)
3 1792299 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 289978 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
HMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.